• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ESBF3214C103E
Medical Device Problem Code Difficult to Remove (1528)
Health Effect - Clinical Codes Hematoma (1884); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/21/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
An endurant iis stent graft was implanted during the endovascular treatment of a 50mm aaa.It was reported that during the index procedure the physician experienced resistance when removing the endurant delivery system from the body post deployment.The physician had to use force to remove the delivery system from the right common femoral artery and the delivery system was severely damaged from the removal process.The patient appeared to have a mild hematoma which resolved upon the completion of the procedure.The physician completed the procedure and obtained hemostasis of the right common femoral artery using a non-medtronic closure device.The delivery system was inspected and appeared normal before use.No deployment issues reported.Per the physician, the cause of he removal difficulties is unknown.No additional clinical sequalae were provided and the patient is fine.
 
Additional Manufacturer Narrative
Product analysis the device returned with the external slider in the home position.The backend wheel was slightly open.The graft cover was partially curved.Bunching and kinking was visible along the graft cover.Excessive bunching was visible distal to the graft cover marker leading to a gap between the tip and the taper tip.A severe kink was visible on the spiral tubing underneath the bunched section.Severe scratches were visible on the taper tip.There was no deformation evident to the spindle.The reported removal difficulties and deformation in-vivo were confirmed through analysis.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT IIS BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key20555169
Report Number9612164-2024-04929
Device Sequence Number19605124
Product Code MIH
UDI-Device Identifier00643169439962
UDI-Public00643169439962
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/04/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/24/2026
Device Model NumberESBF3214C103E
Device Catalogue NumberESBF3214C103E
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/21/2024
Supplement Date Received by Manufacturer04/01/2025
Initial Report FDA Received Date10/29/2024
Supplement Report FDA Received Date04/04/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/24/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age64 YR
Patient SexFemale
-
-